Global Fertility Services Market

Fertility Services Comprehensive Study by Application (Fertility clinics, Hospitals, Surgical centers, Clinical Research Institutes), Treatment (Assistive reproductive technology (ART) (Artificial insemination, In-vitro fertilization (IVF), Frozen Embryo Replacement (FER)), Infertility Drugs), Procedure (In Vitro Fertilization (IVF) With Intracytoplasmic Sperm Injection (ICSI), Surrogacy, IVF without ICSI, Intrauterine Insemination (IUI), Others), Service (Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor, Frozen Donor) Players and Region - Global Market Outlook to 2030

Fertility Services Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Fertility Services
Fertility services involve different procedures which are used to treat genetic and fertility issues and assist with conception. These services include different assisted reproductive technology (ART) methods, helping couples or single parents around the world. These services also facilitate treatments, which aid in treating infertility in patients. In vitro fertilization (IVF), surrogacy, artificial insemination, and others are different forms of infertility services, which assists couples with infertility problems, single mothers, and the LGBT (Lesbian, Gay, Bisexual, and Transgender) community to procreate. Further, The rising numbers of women with awareness about fertility services and delayed pregnancies have increased the growth of fertility services market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR9.0%


The fertility services market is fragmented due to the presence of several vendors. Furthermore, advances in fertility treatment have provided women with options to bear children in later years which has lead to the growth of the market. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Fertility Services market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Coopersurgical, Inc. (United States), Ferring B.V (Switzerland), Merck Sharp & Dohme Corporation (United States), Monash IVF (Australia), Vitrolife (Sweden), Abbott Laboratories (United States), Apollo Hospital Enterprise Limited (India) and Care Fertility Group Limited (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Carolinas Fertility Institute (United States), Genea Limited (New Zealand), The John Hopkins Health System Corporation (United States) and Medicover Group (Sweden).

Segmentation Overview
AMA Research has segmented the market of Global Fertility Services market by , Application (Fertility clinics, Hospitals, Surgical centers and Clinical Research Institutes) and Region.



On the basis of geography, the market of Fertility Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Assistive reproductive technology (ART) [Artificial insemination, In-vitro fertilization (IVF), Frozen Embryo Replacement (FER)] will boost the Fertility Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Procedure, the sub-segment i.e. In Vitro Fertilization (IVF) With Intracytoplasmic Sperm Injection (ICSI) will boost the Fertility Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Service, the sub-segment i.e. Fresh Non-Donor will boost the Fertility Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Number of Sperm Donors at Sperm Banks, Growing Awareness through Online Advertisement for Fertility Services and Rising Cases of Prostate Cancer

Market Growth Drivers:
The Upsurge in the Prevalence of Delayed Pregnancy, High Prevalence of Male Infertility, Rapid Rate of Urbanization and Changing Lifestyle and Rise in Health Awareness on Fertility Issue

Challenges:
Reimbursement Issues Related To Fresh IVF Cycles

Restraints:
Costs Associated With Fertility Services

Opportunities:
Technological Advancement in Fertility Services Such as Egg and Embryo Services and IVF

Market Leaders and their expansionary development strategies
In March 2024, Pinnacle Fertility, a leading network of high-performing family-building clinics, recently announced a strategic partnership with Labcorp, a global leader of innovative and comprehensive laboratory services.
In October 2023, Merck, a leading science and technology company, is launching a comprehensive Fertility Benefit program in October 2023 that will offer employees financial support for fertility treatments. The program will be launched in eight markets: Germany, the United Kingdom, Switzerland, China, India, Taiwan, Brazil, and Mexico. To date, Merck offers similar benefits to employees in the United States, Canada, and Japan. An expansion of the offering to Merck employees in further countries is planned to start next year.


Key Target Audience
Fertility Services Manufacturers, Government and Regulatory Bodies, Health Care Organizations, Potential Investors, Downstream Vendors and Industry Associations

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Fertility clinics
  • Hospitals
  • Surgical centers
  • Clinical Research Institutes
By Treatment
  • Assistive reproductive technology (ART) [Artificial insemination, In-vitro fertilization (IVF), Frozen Embryo Replacement (FER)]
  • Infertility Drugs

By Procedure
  • In Vitro Fertilization (IVF) With Intracytoplasmic Sperm Injection (ICSI)
  • Surrogacy
  • IVF without ICSI
  • Intrauterine Insemination (IUI)
  • Others

By Service
  • Fresh Non-Donor
  • Frozen Non-Donor
  • Egg and Embryo Banking
  • Fresh Donor
  • Frozen Donor

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Upsurge in the Prevalence of Delayed Pregnancy
      • 3.2.2. High Prevalence of Male Infertility
      • 3.2.3. Rapid Rate of Urbanization and Changing Lifestyle
      • 3.2.4. Rise in Health Awareness on Fertility Issue
    • 3.3. Market Challenges
      • 3.3.1. Reimbursement Issues Related To Fresh IVF Cycles
    • 3.4. Market Trends
      • 3.4.1. Increasing Number of Sperm Donors at Sperm Banks
      • 3.4.2. Growing Awareness through Online Advertisement for Fertility Services
      • 3.4.3. Rising Cases of Prostate Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fertility Services, by Application, Treatment, Procedure, Service and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Fertility Services (Value)
      • 5.2.1. Global Fertility Services by: Application (Value)
        • 5.2.1.1. Fertility clinics
        • 5.2.1.2. Hospitals
        • 5.2.1.3. Surgical centers
        • 5.2.1.4. Clinical Research Institutes
      • 5.2.2. Global Fertility Services by: Treatment (Value)
        • 5.2.2.1. Assistive reproductive technology (ART) [Artificial insemination, In-vitro fertilization (IVF), Frozen Embryo Replacement (FER)]
        • 5.2.2.2. Infertility Drugs
      • 5.2.3. Global Fertility Services by: Procedure (Value)
        • 5.2.3.1. In Vitro Fertilization (IVF) With Intracytoplasmic Sperm Injection (ICSI)
        • 5.2.3.2. Surrogacy
        • 5.2.3.3. IVF without ICSI
        • 5.2.3.4. Intrauterine Insemination (IUI)
        • 5.2.3.5. Others
      • 5.2.4. Global Fertility Services by: Service (Value)
        • 5.2.4.1. Fresh Non-Donor
        • 5.2.4.2. Frozen Non-Donor
        • 5.2.4.3. Egg and Embryo Banking
        • 5.2.4.4. Fresh Donor
        • 5.2.4.5. Frozen Donor
      • 5.2.5. Global Fertility Services Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Fertility Services (Price)
  • 6. Fertility Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Coopersurgical, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ferring B.V (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck Sharp & Dohme Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Monash IVF (Australia)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Vitrolife (Sweden)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abbott Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Apollo Hospital Enterprise Limited (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Care Fertility Group Limited (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Fertility Services Sale, by Application, Treatment, Procedure, Service and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Fertility Services (Value)
      • 7.2.1. Global Fertility Services by: Application (Value)
        • 7.2.1.1. Fertility clinics
        • 7.2.1.2. Hospitals
        • 7.2.1.3. Surgical centers
        • 7.2.1.4. Clinical Research Institutes
      • 7.2.2. Global Fertility Services by: Treatment (Value)
        • 7.2.2.1. Assistive reproductive technology (ART) [Artificial insemination, In-vitro fertilization (IVF), Frozen Embryo Replacement (FER)]
        • 7.2.2.2. Infertility Drugs
      • 7.2.3. Global Fertility Services by: Procedure (Value)
        • 7.2.3.1. In Vitro Fertilization (IVF) With Intracytoplasmic Sperm Injection (ICSI)
        • 7.2.3.2. Surrogacy
        • 7.2.3.3. IVF without ICSI
        • 7.2.3.4. Intrauterine Insemination (IUI)
        • 7.2.3.5. Others
      • 7.2.4. Global Fertility Services by: Service (Value)
        • 7.2.4.1. Fresh Non-Donor
        • 7.2.4.2. Frozen Non-Donor
        • 7.2.4.3. Egg and Embryo Banking
        • 7.2.4.4. Fresh Donor
        • 7.2.4.5. Frozen Donor
      • 7.2.5. Global Fertility Services Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Fertility Services (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fertility Services: by Application(USD Million)
  • Table 2. Fertility Services Fertility clinics , by Region USD Million (2018-2023)
  • Table 3. Fertility Services Hospitals , by Region USD Million (2018-2023)
  • Table 4. Fertility Services Surgical centers , by Region USD Million (2018-2023)
  • Table 5. Fertility Services Clinical Research Institutes , by Region USD Million (2018-2023)
  • Table 6. Fertility Services: by Treatment(USD Million)
  • Table 7. Fertility Services Assistive reproductive technology (ART) [Artificial insemination, In-vitro fertilization (IVF), Frozen Embryo Replacement (FER)] , by Region USD Million (2018-2023)
  • Table 8. Fertility Services Infertility Drugs , by Region USD Million (2018-2023)
  • Table 9. Fertility Services: by Procedure(USD Million)
  • Table 10. Fertility Services In Vitro Fertilization (IVF) With Intracytoplasmic Sperm Injection (ICSI) , by Region USD Million (2018-2023)
  • Table 11. Fertility Services Surrogacy , by Region USD Million (2018-2023)
  • Table 12. Fertility Services IVF without ICSI , by Region USD Million (2018-2023)
  • Table 13. Fertility Services Intrauterine Insemination (IUI) , by Region USD Million (2018-2023)
  • Table 14. Fertility Services Others , by Region USD Million (2018-2023)
  • Table 15. Fertility Services: by Service(USD Million)
  • Table 16. Fertility Services Fresh Non-Donor , by Region USD Million (2018-2023)
  • Table 17. Fertility Services Frozen Non-Donor , by Region USD Million (2018-2023)
  • Table 18. Fertility Services Egg and Embryo Banking , by Region USD Million (2018-2023)
  • Table 19. Fertility Services Fresh Donor , by Region USD Million (2018-2023)
  • Table 20. Fertility Services Frozen Donor , by Region USD Million (2018-2023)
  • Table 21. South America Fertility Services, by Country USD Million (2018-2023)
  • Table 22. South America Fertility Services, by Application USD Million (2018-2023)
  • Table 23. South America Fertility Services, by Treatment USD Million (2018-2023)
  • Table 24. South America Fertility Services, by Procedure USD Million (2018-2023)
  • Table 25. South America Fertility Services, by Service USD Million (2018-2023)
  • Table 26. Brazil Fertility Services, by Application USD Million (2018-2023)
  • Table 27. Brazil Fertility Services, by Treatment USD Million (2018-2023)
  • Table 28. Brazil Fertility Services, by Procedure USD Million (2018-2023)
  • Table 29. Brazil Fertility Services, by Service USD Million (2018-2023)
  • Table 30. Argentina Fertility Services, by Application USD Million (2018-2023)
  • Table 31. Argentina Fertility Services, by Treatment USD Million (2018-2023)
  • Table 32. Argentina Fertility Services, by Procedure USD Million (2018-2023)
  • Table 33. Argentina Fertility Services, by Service USD Million (2018-2023)
  • Table 34. Rest of South America Fertility Services, by Application USD Million (2018-2023)
  • Table 35. Rest of South America Fertility Services, by Treatment USD Million (2018-2023)
  • Table 36. Rest of South America Fertility Services, by Procedure USD Million (2018-2023)
  • Table 37. Rest of South America Fertility Services, by Service USD Million (2018-2023)
  • Table 38. Asia Pacific Fertility Services, by Country USD Million (2018-2023)
  • Table 39. Asia Pacific Fertility Services, by Application USD Million (2018-2023)
  • Table 40. Asia Pacific Fertility Services, by Treatment USD Million (2018-2023)
  • Table 41. Asia Pacific Fertility Services, by Procedure USD Million (2018-2023)
  • Table 42. Asia Pacific Fertility Services, by Service USD Million (2018-2023)
  • Table 43. China Fertility Services, by Application USD Million (2018-2023)
  • Table 44. China Fertility Services, by Treatment USD Million (2018-2023)
  • Table 45. China Fertility Services, by Procedure USD Million (2018-2023)
  • Table 46. China Fertility Services, by Service USD Million (2018-2023)
  • Table 47. Japan Fertility Services, by Application USD Million (2018-2023)
  • Table 48. Japan Fertility Services, by Treatment USD Million (2018-2023)
  • Table 49. Japan Fertility Services, by Procedure USD Million (2018-2023)
  • Table 50. Japan Fertility Services, by Service USD Million (2018-2023)
  • Table 51. India Fertility Services, by Application USD Million (2018-2023)
  • Table 52. India Fertility Services, by Treatment USD Million (2018-2023)
  • Table 53. India Fertility Services, by Procedure USD Million (2018-2023)
  • Table 54. India Fertility Services, by Service USD Million (2018-2023)
  • Table 55. South Korea Fertility Services, by Application USD Million (2018-2023)
  • Table 56. South Korea Fertility Services, by Treatment USD Million (2018-2023)
  • Table 57. South Korea Fertility Services, by Procedure USD Million (2018-2023)
  • Table 58. South Korea Fertility Services, by Service USD Million (2018-2023)
  • Table 59. Taiwan Fertility Services, by Application USD Million (2018-2023)
  • Table 60. Taiwan Fertility Services, by Treatment USD Million (2018-2023)
  • Table 61. Taiwan Fertility Services, by Procedure USD Million (2018-2023)
  • Table 62. Taiwan Fertility Services, by Service USD Million (2018-2023)
  • Table 63. Australia Fertility Services, by Application USD Million (2018-2023)
  • Table 64. Australia Fertility Services, by Treatment USD Million (2018-2023)
  • Table 65. Australia Fertility Services, by Procedure USD Million (2018-2023)
  • Table 66. Australia Fertility Services, by Service USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Fertility Services, by Application USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Fertility Services, by Treatment USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Fertility Services, by Procedure USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Fertility Services, by Service USD Million (2018-2023)
  • Table 71. Europe Fertility Services, by Country USD Million (2018-2023)
  • Table 72. Europe Fertility Services, by Application USD Million (2018-2023)
  • Table 73. Europe Fertility Services, by Treatment USD Million (2018-2023)
  • Table 74. Europe Fertility Services, by Procedure USD Million (2018-2023)
  • Table 75. Europe Fertility Services, by Service USD Million (2018-2023)
  • Table 76. Germany Fertility Services, by Application USD Million (2018-2023)
  • Table 77. Germany Fertility Services, by Treatment USD Million (2018-2023)
  • Table 78. Germany Fertility Services, by Procedure USD Million (2018-2023)
  • Table 79. Germany Fertility Services, by Service USD Million (2018-2023)
  • Table 80. France Fertility Services, by Application USD Million (2018-2023)
  • Table 81. France Fertility Services, by Treatment USD Million (2018-2023)
  • Table 82. France Fertility Services, by Procedure USD Million (2018-2023)
  • Table 83. France Fertility Services, by Service USD Million (2018-2023)
  • Table 84. Italy Fertility Services, by Application USD Million (2018-2023)
  • Table 85. Italy Fertility Services, by Treatment USD Million (2018-2023)
  • Table 86. Italy Fertility Services, by Procedure USD Million (2018-2023)
  • Table 87. Italy Fertility Services, by Service USD Million (2018-2023)
  • Table 88. United Kingdom Fertility Services, by Application USD Million (2018-2023)
  • Table 89. United Kingdom Fertility Services, by Treatment USD Million (2018-2023)
  • Table 90. United Kingdom Fertility Services, by Procedure USD Million (2018-2023)
  • Table 91. United Kingdom Fertility Services, by Service USD Million (2018-2023)
  • Table 92. Netherlands Fertility Services, by Application USD Million (2018-2023)
  • Table 93. Netherlands Fertility Services, by Treatment USD Million (2018-2023)
  • Table 94. Netherlands Fertility Services, by Procedure USD Million (2018-2023)
  • Table 95. Netherlands Fertility Services, by Service USD Million (2018-2023)
  • Table 96. Rest of Europe Fertility Services, by Application USD Million (2018-2023)
  • Table 97. Rest of Europe Fertility Services, by Treatment USD Million (2018-2023)
  • Table 98. Rest of Europe Fertility Services, by Procedure USD Million (2018-2023)
  • Table 99. Rest of Europe Fertility Services, by Service USD Million (2018-2023)
  • Table 100. MEA Fertility Services, by Country USD Million (2018-2023)
  • Table 101. MEA Fertility Services, by Application USD Million (2018-2023)
  • Table 102. MEA Fertility Services, by Treatment USD Million (2018-2023)
  • Table 103. MEA Fertility Services, by Procedure USD Million (2018-2023)
  • Table 104. MEA Fertility Services, by Service USD Million (2018-2023)
  • Table 105. Middle East Fertility Services, by Application USD Million (2018-2023)
  • Table 106. Middle East Fertility Services, by Treatment USD Million (2018-2023)
  • Table 107. Middle East Fertility Services, by Procedure USD Million (2018-2023)
  • Table 108. Middle East Fertility Services, by Service USD Million (2018-2023)
  • Table 109. Africa Fertility Services, by Application USD Million (2018-2023)
  • Table 110. Africa Fertility Services, by Treatment USD Million (2018-2023)
  • Table 111. Africa Fertility Services, by Procedure USD Million (2018-2023)
  • Table 112. Africa Fertility Services, by Service USD Million (2018-2023)
  • Table 113. North America Fertility Services, by Country USD Million (2018-2023)
  • Table 114. North America Fertility Services, by Application USD Million (2018-2023)
  • Table 115. North America Fertility Services, by Treatment USD Million (2018-2023)
  • Table 116. North America Fertility Services, by Procedure USD Million (2018-2023)
  • Table 117. North America Fertility Services, by Service USD Million (2018-2023)
  • Table 118. United States Fertility Services, by Application USD Million (2018-2023)
  • Table 119. United States Fertility Services, by Treatment USD Million (2018-2023)
  • Table 120. United States Fertility Services, by Procedure USD Million (2018-2023)
  • Table 121. United States Fertility Services, by Service USD Million (2018-2023)
  • Table 122. Canada Fertility Services, by Application USD Million (2018-2023)
  • Table 123. Canada Fertility Services, by Treatment USD Million (2018-2023)
  • Table 124. Canada Fertility Services, by Procedure USD Million (2018-2023)
  • Table 125. Canada Fertility Services, by Service USD Million (2018-2023)
  • Table 126. Mexico Fertility Services, by Application USD Million (2018-2023)
  • Table 127. Mexico Fertility Services, by Treatment USD Million (2018-2023)
  • Table 128. Mexico Fertility Services, by Procedure USD Million (2018-2023)
  • Table 129. Mexico Fertility Services, by Service USD Million (2018-2023)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Fertility Services: by Application(USD Million)
  • Table 139. Fertility Services Fertility clinics , by Region USD Million (2025-2030)
  • Table 140. Fertility Services Hospitals , by Region USD Million (2025-2030)
  • Table 141. Fertility Services Surgical centers , by Region USD Million (2025-2030)
  • Table 142. Fertility Services Clinical Research Institutes , by Region USD Million (2025-2030)
  • Table 143. Fertility Services: by Treatment(USD Million)
  • Table 144. Fertility Services Assistive reproductive technology (ART) [Artificial insemination, In-vitro fertilization (IVF), Frozen Embryo Replacement (FER)] , by Region USD Million (2025-2030)
  • Table 145. Fertility Services Infertility Drugs , by Region USD Million (2025-2030)
  • Table 146. Fertility Services: by Procedure(USD Million)
  • Table 147. Fertility Services In Vitro Fertilization (IVF) With Intracytoplasmic Sperm Injection (ICSI) , by Region USD Million (2025-2030)
  • Table 148. Fertility Services Surrogacy , by Region USD Million (2025-2030)
  • Table 149. Fertility Services IVF without ICSI , by Region USD Million (2025-2030)
  • Table 150. Fertility Services Intrauterine Insemination (IUI) , by Region USD Million (2025-2030)
  • Table 151. Fertility Services Others , by Region USD Million (2025-2030)
  • Table 152. Fertility Services: by Service(USD Million)
  • Table 153. Fertility Services Fresh Non-Donor , by Region USD Million (2025-2030)
  • Table 154. Fertility Services Frozen Non-Donor , by Region USD Million (2025-2030)
  • Table 155. Fertility Services Egg and Embryo Banking , by Region USD Million (2025-2030)
  • Table 156. Fertility Services Fresh Donor , by Region USD Million (2025-2030)
  • Table 157. Fertility Services Frozen Donor , by Region USD Million (2025-2030)
  • Table 158. South America Fertility Services, by Country USD Million (2025-2030)
  • Table 159. South America Fertility Services, by Application USD Million (2025-2030)
  • Table 160. South America Fertility Services, by Treatment USD Million (2025-2030)
  • Table 161. South America Fertility Services, by Procedure USD Million (2025-2030)
  • Table 162. South America Fertility Services, by Service USD Million (2025-2030)
  • Table 163. Brazil Fertility Services, by Application USD Million (2025-2030)
  • Table 164. Brazil Fertility Services, by Treatment USD Million (2025-2030)
  • Table 165. Brazil Fertility Services, by Procedure USD Million (2025-2030)
  • Table 166. Brazil Fertility Services, by Service USD Million (2025-2030)
  • Table 167. Argentina Fertility Services, by Application USD Million (2025-2030)
  • Table 168. Argentina Fertility Services, by Treatment USD Million (2025-2030)
  • Table 169. Argentina Fertility Services, by Procedure USD Million (2025-2030)
  • Table 170. Argentina Fertility Services, by Service USD Million (2025-2030)
  • Table 171. Rest of South America Fertility Services, by Application USD Million (2025-2030)
  • Table 172. Rest of South America Fertility Services, by Treatment USD Million (2025-2030)
  • Table 173. Rest of South America Fertility Services, by Procedure USD Million (2025-2030)
  • Table 174. Rest of South America Fertility Services, by Service USD Million (2025-2030)
  • Table 175. Asia Pacific Fertility Services, by Country USD Million (2025-2030)
  • Table 176. Asia Pacific Fertility Services, by Application USD Million (2025-2030)
  • Table 177. Asia Pacific Fertility Services, by Treatment USD Million (2025-2030)
  • Table 178. Asia Pacific Fertility Services, by Procedure USD Million (2025-2030)
  • Table 179. Asia Pacific Fertility Services, by Service USD Million (2025-2030)
  • Table 180. China Fertility Services, by Application USD Million (2025-2030)
  • Table 181. China Fertility Services, by Treatment USD Million (2025-2030)
  • Table 182. China Fertility Services, by Procedure USD Million (2025-2030)
  • Table 183. China Fertility Services, by Service USD Million (2025-2030)
  • Table 184. Japan Fertility Services, by Application USD Million (2025-2030)
  • Table 185. Japan Fertility Services, by Treatment USD Million (2025-2030)
  • Table 186. Japan Fertility Services, by Procedure USD Million (2025-2030)
  • Table 187. Japan Fertility Services, by Service USD Million (2025-2030)
  • Table 188. India Fertility Services, by Application USD Million (2025-2030)
  • Table 189. India Fertility Services, by Treatment USD Million (2025-2030)
  • Table 190. India Fertility Services, by Procedure USD Million (2025-2030)
  • Table 191. India Fertility Services, by Service USD Million (2025-2030)
  • Table 192. South Korea Fertility Services, by Application USD Million (2025-2030)
  • Table 193. South Korea Fertility Services, by Treatment USD Million (2025-2030)
  • Table 194. South Korea Fertility Services, by Procedure USD Million (2025-2030)
  • Table 195. South Korea Fertility Services, by Service USD Million (2025-2030)
  • Table 196. Taiwan Fertility Services, by Application USD Million (2025-2030)
  • Table 197. Taiwan Fertility Services, by Treatment USD Million (2025-2030)
  • Table 198. Taiwan Fertility Services, by Procedure USD Million (2025-2030)
  • Table 199. Taiwan Fertility Services, by Service USD Million (2025-2030)
  • Table 200. Australia Fertility Services, by Application USD Million (2025-2030)
  • Table 201. Australia Fertility Services, by Treatment USD Million (2025-2030)
  • Table 202. Australia Fertility Services, by Procedure USD Million (2025-2030)
  • Table 203. Australia Fertility Services, by Service USD Million (2025-2030)
  • Table 204. Rest of Asia-Pacific Fertility Services, by Application USD Million (2025-2030)
  • Table 205. Rest of Asia-Pacific Fertility Services, by Treatment USD Million (2025-2030)
  • Table 206. Rest of Asia-Pacific Fertility Services, by Procedure USD Million (2025-2030)
  • Table 207. Rest of Asia-Pacific Fertility Services, by Service USD Million (2025-2030)
  • Table 208. Europe Fertility Services, by Country USD Million (2025-2030)
  • Table 209. Europe Fertility Services, by Application USD Million (2025-2030)
  • Table 210. Europe Fertility Services, by Treatment USD Million (2025-2030)
  • Table 211. Europe Fertility Services, by Procedure USD Million (2025-2030)
  • Table 212. Europe Fertility Services, by Service USD Million (2025-2030)
  • Table 213. Germany Fertility Services, by Application USD Million (2025-2030)
  • Table 214. Germany Fertility Services, by Treatment USD Million (2025-2030)
  • Table 215. Germany Fertility Services, by Procedure USD Million (2025-2030)
  • Table 216. Germany Fertility Services, by Service USD Million (2025-2030)
  • Table 217. France Fertility Services, by Application USD Million (2025-2030)
  • Table 218. France Fertility Services, by Treatment USD Million (2025-2030)
  • Table 219. France Fertility Services, by Procedure USD Million (2025-2030)
  • Table 220. France Fertility Services, by Service USD Million (2025-2030)
  • Table 221. Italy Fertility Services, by Application USD Million (2025-2030)
  • Table 222. Italy Fertility Services, by Treatment USD Million (2025-2030)
  • Table 223. Italy Fertility Services, by Procedure USD Million (2025-2030)
  • Table 224. Italy Fertility Services, by Service USD Million (2025-2030)
  • Table 225. United Kingdom Fertility Services, by Application USD Million (2025-2030)
  • Table 226. United Kingdom Fertility Services, by Treatment USD Million (2025-2030)
  • Table 227. United Kingdom Fertility Services, by Procedure USD Million (2025-2030)
  • Table 228. United Kingdom Fertility Services, by Service USD Million (2025-2030)
  • Table 229. Netherlands Fertility Services, by Application USD Million (2025-2030)
  • Table 230. Netherlands Fertility Services, by Treatment USD Million (2025-2030)
  • Table 231. Netherlands Fertility Services, by Procedure USD Million (2025-2030)
  • Table 232. Netherlands Fertility Services, by Service USD Million (2025-2030)
  • Table 233. Rest of Europe Fertility Services, by Application USD Million (2025-2030)
  • Table 234. Rest of Europe Fertility Services, by Treatment USD Million (2025-2030)
  • Table 235. Rest of Europe Fertility Services, by Procedure USD Million (2025-2030)
  • Table 236. Rest of Europe Fertility Services, by Service USD Million (2025-2030)
  • Table 237. MEA Fertility Services, by Country USD Million (2025-2030)
  • Table 238. MEA Fertility Services, by Application USD Million (2025-2030)
  • Table 239. MEA Fertility Services, by Treatment USD Million (2025-2030)
  • Table 240. MEA Fertility Services, by Procedure USD Million (2025-2030)
  • Table 241. MEA Fertility Services, by Service USD Million (2025-2030)
  • Table 242. Middle East Fertility Services, by Application USD Million (2025-2030)
  • Table 243. Middle East Fertility Services, by Treatment USD Million (2025-2030)
  • Table 244. Middle East Fertility Services, by Procedure USD Million (2025-2030)
  • Table 245. Middle East Fertility Services, by Service USD Million (2025-2030)
  • Table 246. Africa Fertility Services, by Application USD Million (2025-2030)
  • Table 247. Africa Fertility Services, by Treatment USD Million (2025-2030)
  • Table 248. Africa Fertility Services, by Procedure USD Million (2025-2030)
  • Table 249. Africa Fertility Services, by Service USD Million (2025-2030)
  • Table 250. North America Fertility Services, by Country USD Million (2025-2030)
  • Table 251. North America Fertility Services, by Application USD Million (2025-2030)
  • Table 252. North America Fertility Services, by Treatment USD Million (2025-2030)
  • Table 253. North America Fertility Services, by Procedure USD Million (2025-2030)
  • Table 254. North America Fertility Services, by Service USD Million (2025-2030)
  • Table 255. United States Fertility Services, by Application USD Million (2025-2030)
  • Table 256. United States Fertility Services, by Treatment USD Million (2025-2030)
  • Table 257. United States Fertility Services, by Procedure USD Million (2025-2030)
  • Table 258. United States Fertility Services, by Service USD Million (2025-2030)
  • Table 259. Canada Fertility Services, by Application USD Million (2025-2030)
  • Table 260. Canada Fertility Services, by Treatment USD Million (2025-2030)
  • Table 261. Canada Fertility Services, by Procedure USD Million (2025-2030)
  • Table 262. Canada Fertility Services, by Service USD Million (2025-2030)
  • Table 263. Mexico Fertility Services, by Application USD Million (2025-2030)
  • Table 264. Mexico Fertility Services, by Treatment USD Million (2025-2030)
  • Table 265. Mexico Fertility Services, by Procedure USD Million (2025-2030)
  • Table 266. Mexico Fertility Services, by Service USD Million (2025-2030)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fertility Services: by Application USD Million (2018-2023)
  • Figure 5. Global Fertility Services: by Treatment USD Million (2018-2023)
  • Figure 6. Global Fertility Services: by Procedure USD Million (2018-2023)
  • Figure 7. Global Fertility Services: by Service USD Million (2018-2023)
  • Figure 8. South America Fertility Services Share (%), by Country
  • Figure 9. Asia Pacific Fertility Services Share (%), by Country
  • Figure 10. Europe Fertility Services Share (%), by Country
  • Figure 11. MEA Fertility Services Share (%), by Country
  • Figure 12. North America Fertility Services Share (%), by Country
  • Figure 13. Global Fertility Services share by Players 2023 (%)
  • Figure 14. Global Fertility Services share by Players (Top 3) 2023(%)
  • Figure 15. Global Fertility Services share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Coopersurgical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Coopersurgical, Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Ferring B.V (Switzerland) Revenue, Net Income and Gross profit
  • Figure 20. Ferring B.V (Switzerland) Revenue: by Geography 2023
  • Figure 21. Merck Sharp & Dohme Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Merck Sharp & Dohme Corporation (United States) Revenue: by Geography 2023
  • Figure 23. Monash IVF (Australia) Revenue, Net Income and Gross profit
  • Figure 24. Monash IVF (Australia) Revenue: by Geography 2023
  • Figure 25. Vitrolife (Sweden) Revenue, Net Income and Gross profit
  • Figure 26. Vitrolife (Sweden) Revenue: by Geography 2023
  • Figure 27. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 29. Apollo Hospital Enterprise Limited (India) Revenue, Net Income and Gross profit
  • Figure 30. Apollo Hospital Enterprise Limited (India) Revenue: by Geography 2023
  • Figure 31. Care Fertility Group Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Care Fertility Group Limited (United Kingdom) Revenue: by Geography 2023
  • Figure 33. Global Fertility Services: by Application USD Million (2025-2030)
  • Figure 34. Global Fertility Services: by Treatment USD Million (2025-2030)
  • Figure 35. Global Fertility Services: by Procedure USD Million (2025-2030)
  • Figure 36. Global Fertility Services: by Service USD Million (2025-2030)
  • Figure 37. South America Fertility Services Share (%), by Country
  • Figure 38. Asia Pacific Fertility Services Share (%), by Country
  • Figure 39. Europe Fertility Services Share (%), by Country
  • Figure 40. MEA Fertility Services Share (%), by Country
  • Figure 41. North America Fertility Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Coopersurgical, Inc. (United States)
  • Ferring B.V (Switzerland)
  • Merck Sharp & Dohme Corporation (United States)
  • Monash IVF (Australia)
  • Vitrolife (Sweden)
  • Abbott Laboratories (United States)
  • Apollo Hospital Enterprise Limited (India)
  • Care Fertility Group Limited (United Kingdom)
Additional players considered in the study are as follows:
Carolinas Fertility Institute (United States) , Genea Limited (New Zealand) , The John Hopkins Health System Corporation (United States) , Medicover Group (Sweden)
Select User Access Type

Key Highlights of Report


Apr 2024 226 Pages 66 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Fertility Services Market Quantitative research analysis
Global Fertility Services Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Coopersurgical, Inc. (United States), Ferring B.V (Switzerland), Merck Sharp & Dohme Corporation (United States), Monash IVF (Australia), Vitrolife (Sweden), Abbott Laboratories (United States), Apollo Hospital Enterprise Limited (India) and Care Fertility Group Limited (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Number of Sperm Donors at Sperm Banks " is seen as one of major influencing trends for Fertility Services Market during projected period 2023-2030.
The Fertility Services market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Fertility Services Market Report?

Have a Query? Click Here

Other Related Reports

Healthcare Interoperability Solutions Comprehensive Study by Type (Software Solutions {EMR/EHR, Lab Systems, Imaging Systems, Healthcare Information Exchange, Enterprise, Other(Medical Billing, Pract...
$ 3750
Dental Restorative Comprehensive Study by Type (Dental amalgams, Dental cements, Dental composites, Dental ceramics, Dental liners), Application (Prosthodontics, Periodontics,, Periodontics), End Use...
$ 3450
Lung Transplant Rejection Comprehensive Study by Type (Cellular Rejection, Antibody-Mediated Rejections, Allograft Rejection, Acute Rejections, Chronic Rejections), Application (Lung Transplant Patie...
$ 3500
Interventional Pulmonology Comprehensive Study by Type (Bronchoscopes, Electromagnetic Navigation Bronchoscopy Systems, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters...
$ 3750
Biopreservation Comprehensive Study by Type (Biopreservation Media, Biopreservation Equipment, Others), Application (Biobanking, Regenerative Medicine, Drug Discovery, Others), End Users (Biobanks, H...
$ 3800
Chromatography Based Cannabis Comprehensive Study by Type (High-Performance Liquid Chromatography, Gas Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography), Application (Pai...
$ 3350